Topics
News
CME/CE
Editorial Advisory Board
Partnerships
New AK therapies offer tx choices
National Report - With the rapid onset of new therapies available for the treatment of actinic keratosis (AK), Stacy Smith, M.D. of Therapeutics Clinical Research in California, has demonstrated that efficacy, tolerability and cost play a combined role in the approach used to treat AK.
Related Videos
Related Content
